The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
The Dutch group is ripe for a takeover, and while Thermo Fisher has to be the likeliest candidate for acquirer there are a number of potentially interested parties.
Two dental companies go public inside a week, with very different results.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Exact Sciences finds that where there’s muck there’s brass, but specialisation does not work as well for Abiomed.
GE sells its Biopharma business for $21.4bn, but is its IPO cancelled or merely on hold?